We provide you with 20 years of free, institutional-grade data for ACLX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ACLX. Explore the full financial landscape of ACLX stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-08-07 | 1786205 | ACLX | 10-Q | Url |
| 2025-05-08 | 1786205 | ACLX | 10-Q | Url |
| 2025-02-27 | 1786205 | ACLX | 10-K | Url |
| 2024-11-07 | 1786205 | ACLX | 10-Q | Url |
| 2024-08-08 | 1786205 | ACLX | 10-Q | Url |
| 2024-05-09 | 1786205 | ACLX | 10-Q | Url |
| 2024-02-28 | 1786205 | ACLX | 10-K | Url |
| 2023-11-13 | 1786205 | ACLX | 10-Q | Url |
| 2023-08-14 | 1786205 | ACLX | 10-Q | Url |
| 2023-05-08 | 1786205 | ACLX | 10-Q | Url |
| 2023-03-29 | 1786205 | ACLX | 10-K | Url |
| 2022-11-14 | 1786205 | ACLX | 10-Q | Url |
| 2022-08-15 | 1786205 | ACLX | 10-Q | Url |
| 2022-06-14 | 1786205 | ACLX | S-1 | Url |
| 2022-05-12 | 1786205 | ACLX | 10-Q | Url |
| 2022-03-24 | 1786205 | ACLX | 10-K | Url |
| 2022-01-14 | 1786205 | ACLX | S-1 | Url |
Arcellx Inc.(NASDAQ:ACLX) 
Arcellx, Inc., a clinical-stage biotechnology company, is engaged in the development of various immunotherapies for patients with cancer and other incurable diseases. The company is headquartered in Gaithersburg, Maryland.
The information provided in this report about ACLX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.